Home/Investors/Eli Lilly and Company

Eli Lilly and Company

Biotech Investor · 2 portfolio companies

Portfolio

2

Focus Areas

4

Top Stage

Pre-clinical

Investment Focus

Oncology Chronic Pain Autoimmunity Cardiovascular Disease

Portfolio Companies

Company	Stage	Valuation	Focus
Myricx Bio	Pre-clinical	—	Oncology
Maxion Therapeutics	Pre-clinical	—	Chronic Pain, Autoimmunity

Frequent Co-Investors

Sofinnova Partners1 shared Novo Holdings1 shared Cancer Research Horizons1 shared Abingworth1 shared General Catalyst1 shared Monograph Capital1 shared LifeArc Ventures1 shared British Business Bank1 shared